NSF International provides an extensive range of high-quality support services to the pharmaceutical and biotech industries.
You have successfully submitted your enquiry. Someone from our company will respond ASAP
NSF International provides an extensive range of high-quality support services to the pharmaceutical and biotech industries.
The company’s pharmaceutical offerings include both residential and on-site training, consulting, auditing and regulatory support services, bringing high quality and safety.
Throughout 2018, NSF International:
NSF provides a comprehensive range of pharmaceutical support services, including consulting, auditing, training and regulatory compliance. The company helps clients address industry challenges and public health and safety concerns, as well as meet the stringent requirements of the pharmaceutical industry.
NSF is recognised by industry experts as a partner for clinical services, regulatory compliance consulting, training and auditing.
NSF International offers an extensive range of professional pharmaceutical training courses, which help clients with continuing professional development (CPD) for the pharmaceutical industry.
The courses cover many subjects and are designed to help professionals prepare for the next challenge by improving competitiveness and building knowledge.
Courses are aimed to improve operational excellence and competitive edge. They can be brought on-site and customised to meet client requirements.
Courses topics offered annually include:
The company also works alongside the University of Strathclyde to provide a qualified person (QP) training programme. The course is also approved by the Royal School of Chemistry.
Separate from its training and consultancy work, NSF International helps clients reach a standard of excellence by providing a series of audits, assessments and certifications.
Its auditing and assessment offerings include pharmaceutical data integrity assessments, human error prevention, pharmaceutical auditing of third parties and suppliers, due diligence audits and auditor certification, excipient current good manufacturing practice (cGMP) certification and CAPA system assessment.
NSF International’s remediation consultancy services are designed to strengthen your business by managing warning letters, consent decrees, import alert notifications, product de-listings from the World Health Organisation (WHO) and removal of production and marketing licences in the EU.
NSF International helps manage clients’ pharmaceutical quality system (PQS) to ensure optimal product quality and consistency.
The company aims to either simplify an existing PQS or develop and implement a new competitive system to help benchmark best industry practice.
NSF International‘s pharmaceutical regulatory inspection readiness and mock inspections service helps ensure pharmaceutical regulatory guidelines are met in preparation for US Food and Drug Administration (FDA), EU and WHO inspections.
NSF International’s team of former EU and FDA officials allows the company to offer global regulatory expertise with industry best practices to help clients achieve an effective PQS. NSF International supports the development, manufacturing and marketing of products and has a proven record of success.
Regulatory inspections can be a source of anxiety and uncertainty for many organisations. However, with the right knowledge and preparation, inspections can also be an opportunity to strengthen your operations, demonstrate your commitment to compliance and quality and identify opportunities for continuous improvement.
It is well recognised that the Quality Management System (QMS) — whether documentation, deviation and event management or CAPA — is the focus of Regulatory Inspections and indeed the cause of many findings.
NSF Pharma Biotech's CEO Martin Lush recently had a meeting with a CEO to help solve his company’s pain points.
Making a case for good manufacturing practice (GMP) certification of an excipient manufacturer should be a straightforward exercise since the benefits appear so clear cut and regulatory guidance in the EU underscores the value of certification.
Risk management across a global supply chain has never been a stronger factor in assuring economic success than it is now.
The heart of the European Union (EU) regulation of in vitro diagnostic medical devices (IVDs) lies in allowing market access to IVDs that offer clinical benefit, and are safe to the patient, the user of the IVD and others (such as service technicians).
In the global market, outsourcing is no longer an option, it is an economic necessity.
How can you best prepare for a post-pandemic on-site GMP inspection? We examine the issues in this video and webinar transcript
US-based pharmaceutical company Alcami has relocated its existing analytical testing facility in Missouri to the Cortex Innovation Centre in Central West End, St Louis.
NSF is pleased to announce its 3rd Annual Pharmaceutical Conference, taking place on 23 October 2025 at the Royal Society of Chemistry in London.
Did you know that 7-11 November is World Quality Week? NSF’s Health Sciences team are proud to be taking part.
The final version of the revised Annex 1 was published on 25 August 2022, some seven years after the revision process started. Join our virtual instructor-led course on 25 October to ensure that your contamination control strategy meets the requirements of EU GMP Volume 4 Annex I.
This eLearning provides an overview of ICH Q8 Pharmaceutical Development, ICH Q9 Quality Risk Management (QRM) and Q10 Pharmaceutical Quality System (PQS). It summarises the key principles and benefits that accrue with the effective and collective implementation of ICH Q8,9 and 10.
Join our webinar on Tuesday 10 December at 3PM London / 10AM New York to find out how a strategic and well planned-out remediation effort is principal to long-term maintainable corrections.
Get 50% off NSF’s pharma and medical devices eLearning, £100 off selected one-day courses and £300 off our Responsible Person and Good Distribution Practice course.
Interest in Near Patient Testing (NPT) continues to gain momentum as it has a major role to play in redesigning services around the needs of the patient.
Our NEW Data Integrity eLearning course is now live!
Join NSF’s Lynne Byers, Catherine Kay, Howard Broadbridge and Martin Krainz at the CPhI Worldwide exhibition on November 5-7, 2019.
The transaction generates a single access point for medical device and pharma / biotech product creators seeking integrated, expert services throughout the whole product lifecycle.
NSF will be presenting a Webinar on 8 October at 1:00pm – 1:30pm GMT.
The Manchester Molecular Pathology Innovation Centre (MMPathIC), in collaboration with the Diagnostics and Technology Accelerator (DiTA) and NIHR Manchester Biomedical Research Center, is hosting a workshop on the 23 September at the Manchester Science Partnership Citylabs.
It is with great pleasure that NSF announces their Responsible Person and Good Distribution Practice course now meets the Cogent Gold Standard proficiencies for the role of the RP in Medicinal Products and the accompanying standard.
Spaces for NSF’s September courses are filling fast, so book now to secure a place and do not forget to take advantage of the company’s multi-delegate saving opportunities, in addition to NHS staff, regulator and charity discounts.
NSF will be appearing at ISPE Singapore Conference and Exhibition 2019 on 21-23 August.
Do you manufacture over-the-counter (OTC) drugs for the US market? In this 30-minute NSF webinar, you will learn about the standard development process, key stakeholders, structure and main elements of the NSF/ANSI 455-4-2018 standard.
Two NSF medical device experts took part in panel discussions on June 25 at the MedFIT conference in Lille, France.
NSF has announced its latest upcoming European Pharma Training events coming up this year.
There is not long to go until Making Pharmaceuticals. Are you attending? Make sure you join NSF for a coffee and a chat at stand 216.
NSF International’s pharma webinars are short, interactive sessions featuring its world-leading experts discussing topics of current concern.
NSF has announced that it will be taking part at Making Pharmaceuticals in Coventry, UK.
NSF International announces new updates for its pharma app, which is available on Apple’s App Store and Android’s Google Play.
NSF has announced its new complimentary webinar, How to Install a Data Governance Process from Ground Zero'.
NSF Health Sciences vice-president Martin Lush wants your input to this limited-place 30-minute webinar.
One of the primary roles for Qualified Persons (QP) and other quality professionals is to make sure that the products released for sale are in compliance with the requirements of the marketing authorisation (MA) for that product.
NSF has announced it will be attending the IPEC Europe Excipients Forum in Malta.
From the moment we get out of bed in the morning to when we return at night, we all take risks. Some big, others small. Some consciously, others less so. There is no such thing as zero risk.
NSF International Pharma Biotech has announced a focused, challenging workshop aimed to improve your understanding of human error.
NSF’s executive director and ex-inspector at the medicines and healthcare products regulatory agency (MHRA) Rachel Carmichael will be speaking at the Outsourcing and Supply Chain PDA Europe conference this November in Seville, Spain.
What does the future hold for the qualified person (QP) post-Brexit? There has been much debate on this matter. We do know that all EU centralised marketing authorisations must be held by a legal entity within the EU and that QP certification and pharmacovigilance (PV) need to occur in the EU.
NSF International’s medical devices programme in Europe is shifting senior leadership roles and responsibilities after a subsidiary of the global public health organisation withdrew its notified body designation application for European in-vitro diagnostic (IVD) and medical device regulations (MDR).
NSF International’s pharma biotech team will be exhibiting at CPhI Worldwide in Madrid, Spain this October.
NSF International provides a comprehensive range of support services for the pharmaceutical industry covering consulting, training, auditing, remediation, quality systems and regulatory guidance on a global basis.
NSF has announced a wide range of upcoming courses related to the pharmaceutical industry. Make sure you remember to take advantage of any discounts you could be entitled to. Get in touch if you're interested in bringing any of this training on-site.
NSF will be exhibiting at the 2018 International Pharmaceutical Federation (FIP) World Congress in Glasgow, Scotland.
NSF International has announced up-coming workshops in September, including topics such as incident management and human error prevention.
NSF International provides a comprehensive range of support services for the pharmaceutical industry covering consulting, training, auditing, remediation, quality systems and regulatory guidance on a global basis.
NSF has added two new eLearning sessions to its online portal.
NSF has announced a range of upcoming courses in June and July. Make sure you remember to take advantage of any discounts you could be entitled to. Make an enquiry if you are interested in bringing any of this training on-site.
NSF International has expanded its training offering and now provides pharma biotech eLearning.
NSF has announced the dates for a variety of workshops taking place throughout May and June.
NSF International has announced that there are still some spaces available on some of its upcoming pharmaceutical courses.
NSF International has announced it will be exhibiting at the free-to-attend Making Pharmaceuticals Europe exhibition and conference.
NSF International has announced it will be launching its pharmaceutical biotech e-learning programme in April 2018.
There’s an old saying, 'Proper planning prevents poor performance', and another adage tells us to 'Begin with the end in mind'. Well, what happens when you don’t know what the end looks like? How can you plan for your career, your workplace or your business in a world of chaos and uncertainty? Well, listen in for some practical tips!
NSF International is known all over the world for the high quality of its pharmaceutical training and education.
NSF International has appointed Lynne Byers as executive director and David Waddington as director of its pharmaceutical biotech services in Europe.
NSF has announced the release of a new collection of pharmaceutical workshops for the 2017/2018 period.
To celebrate its 40th anniversary, the Pharmaceutical Quality Group (PQG) is holding an anniversary dinner and a three-day meeting at the Hilton Hotel in Milton Keynes, UK.
NSF’s pharma biotech experts are now providing services to India’s pharmaceutical industry from its Gurugram office.
US Food and Drug Administration (FDA) regulations protect the health, safety, and overall quality of products so they do not adversely affect consumers. That is also why current good manufacturing practices (cGMP) are in place.
NSF Health Sciences has announced it will be hosting a two-part webinar to discuss the new label text guidelines for pharmaceticals.
NSF International has launched a new app designed for pharmaceutical biotech industry executives.
NSF International has released a list of upcoming courses for June and July.
NSF International's pharma biotech team has announced it will be present at the 2nd PDA Europe Annual Meeting in Berlin.
The 21st Century Cures Act stemmed from a political spotlight on two girls that could not get treatment for their rare diseases, as presented by Senator Upton in his opening statement at the Legislative Hearing on 21st Century Cures Act.
Enacted into law December of 2016, the 21st Century Cures Act is an initiative to expedite and enhance the process of discovery, development, and delivery for disease treatments.
NSF International is offering training for lead auditors of quality management systems (QMS) based on both ISO 13485:2016 and international Medical Device Single Audit Plan (MDSAP) requirements.
NSF International is partnering with the Indian Drug Manufacturers' Association (IDMA) to offer a customised, five-module pharmaceutical quality management (PQM) education programme in Bangalore, India.
NSF International has announced the retirement of Bob Pietrowski PhD, a 40-year veteran of the pharmaceutical and medical device industries who has served as vice-president of NSF International's Global Health Sciences Division since 2013. He is being replaced by Martin Lush.
NSF International has announced a new partnership with non-profit organization Textile Exchange to boost sustainability in the textile industry.
NSF-GFTC will now be called NSF International after changing its name.
NSF International has published the first American National Standard for pharmaceutical excipients, NSF/IPEC/ANSI 363: Good Manufacturing Practices (GMP) for Pharmaceutical Excipients.
NSF International will be attending the 54th Annual Meeting and ToxExpo from 22-26 March at San Diego Convention Center.
NSF International has acquired the International Pharmaceutical Excipients Council of the Americas’ (IPEC-Americas) auditing subsidiary, IPEA.
NSF International has integrated subsidiary companies NSF Becker & Associates, NSF-DBA and NSF Pharmalytica, as well as its existing Dietary Supplement Program, into one unified Health Sciences Division.
NSF has released a white paper entitled 'Does your Pharmaceutical Quality System Improve your Competitive Edge?'.
NSF International, an independent global public health organization that develops high quality reference standards, now has Atorvastatin Calcium Reference Standard Kits, which are traceable to official US (USP) and European pharmacopeial (EP) standards.
The International Pharmaceutical Excipients Council of the Americas (IPEC-Americas) - an international non-profit comprised of pharmaceutical and excipient manufacturers and distributors - has approved the sale of its IPEA auditing subsidiary to NSF International.
NSF Becker & Associates Consulting, part of global independent public health organization NSF International, has launched a new program to assist companies in achieving 360 operational compliance to the commercial practices of the life science industry.
NSF Health Science has release five white papers on 510(k) requirements for extractables and leachables; analytical challenges for leachables; FDA excipient regulations; quality in the US pharma industry and new European regulations for medical devices.
NSF International, an independent global public health and safety organization which develops standards, and tests and certifies products for the food, water and health sciences industries, has acquired the INASSA Group of Lima, Peru, which is comprised of three segments: technical analysis, laboratory and sanitation.
The US Food and Drug Administration (FDA) requires extractables and leachables testing for many medical devices.
NSF International, a global independent public health organization that writes standards, and tests and certifies products for the health sciences, water, food, and consumer goods industries, has welcomed three leading pharmaceutical and biotech experts to its Health Sciences Division.
NSF International, an independent global public health and safety organization which develops standards, and tests and certifies products for the pharmaceutical, dietary supplement, food, water, and consumer products industries, is the first to offer Secondary Reference Standards in India, helping meet the growing India pharmaceutical sectors' need for high quality, economical alternatives to pharmacopoeia standards.
NSF's unique team of ex-regulatory agency inspectors and highly experienced industry professionals provide authoritative consulting and auditing services to major pharmaceutical and biopharmaceutical companies and regulatory agencies worldwide.
NSF International provides regulatory solutions and strategic input across a wide variety of therapeutic areas.
NSF has substantial experience in creating, implementing, reviewing, and remediating pharmaceutical quality systems (QS) for a variety of organisations.
NSF International provides high-quality training and education, helping to develop an individual's career progression (including becoming a qualified person), training groups of staff on-site to understand changes in procedures and regulations, and helping to bring culture change within an entire organisation. NSF has the skills and programmes to meet your needs.
Pharmaceutical failure investigations and corrective and preventive action (CAPA) system weaknesses are consistently among the top most frequently cited regulatory observations and the top finding in US Food and Drug Administration (FDA) warning letters.
Data integrity continues to be a hot topic impacting the pharma/biotech industry, and the trend has been growing since 2010.
Executive director of pharma biotech at NSF International Nicholas Markel talks about the relatively new issue of ageing facilities, including what the issue is and how to diagnose and address it.
